Physician profile
Jose Maymi
NPI 1093717639
$13,594.50
in general payments reported to CMS, 2019-2025
36 companies · $869 in 2025
The $869 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $592 · 2021: $1,925 · 2022: $7,094 · 2023: $975 · 2024: $1,277 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.89 |
| Education | $259.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,567.69 | 2022 | |
| Teleflex LLC | $2,460.03 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $1,869.64 | 2019-2023 | Rezum Generator |
| Astellas Pharma US INC | $1,680.28 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $638.36 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $533.03 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $532.01 | 2019-2025 | |
| Procept Biorobotics Corporation | $425.24 | 2022 | |
| Pfizer INC. | $424.91 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $217.81 | 2021-2024 | Xarelto |
| Karl Storz Endoscopy-America | $196.10 | 2019-2024 | |
| Foundation Medicine, INC. | $169.49 | 2020-2023 | |
| Myovant Sciences INC. | $155.92 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $141.99 | 2025 | Provenge |
| Telix Pharmaceuticals | $135.09 | 2023-2024 | Illuccix |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $133.90 | 2019 | |
| Urovant Sciences INC | $131.88 | 2021-2022 | |
| Tolmar, INC. | $126.09 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $115.57 | 2020-2025 | Prolaris |
| Johnson and Johnson International | $112.10 | 2025 | Ethicon |
| Allergan, INC. | $100.00 | 2019 | |
| Cardiovascular Systems INC. | $97.45 | 2021 | |
| Verity Pharmaceuticals INC. | $82.00 | 2021-2023 | Trelstar |
| Antares Pharma, INC. | $80.73 | 2021-2022 | |
| 180 Medical, INC. | $78.28 | 2023-2025 | Cure Catheter |
| Neotract INC. | $69.92 | 2020 | |
| Ferring Pharmaceuticals INC. | $56.01 | 2019-2024 | Adstiladrin |
| Alnylam Pharmaceuticals INC. | $54.89 | 2021-2023 | Givlaari |
| Merck Sharp & Dohme LLC | $51.88 | 2021-2022 | |
| Astellas Pharma Global Development | $38.56 | 2019 | |
| Convatec INC. | $33.92 | 2023 | |
| Amgen INC. | $21.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 2024 | Krazati |
| Travere Therapeutics, INC. | $16.40 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $16.07 | 2023 | |
| Dentsply Ih INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Maymi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.